We are live on ! Find out more
WCM

Wildcat Capital Management Portfolio holdings

AUM $229M
1-Year Est. Return 132.65%
This Fund
S&P 500
This Quarter Est. Return
+16.54%
1 Year Est. Return
+132.65%
3 Year Est. Return
+125.67%
5 Year Est. Return
+54.1%
10 Year Est. Return
+1,929.91%
AUM
$94M
AUM Growth
-$464M
Cap. Flow
-$474M
Cap. Flow %
-504.55%
Top 10 Hldgs %
99.35%
Holding
18
New
2
Increased
1
Reduced
5
Closed
7

Top Buys

Rank Stock Value
1
APPF icon
AppFolio
APPF
+$2.57M
2
SBR
Sabine Royalty Trust
SBR
+$2.27M

Sector Composition

Rank Sector Weight
1 Real Estate 48.34%
2 Financials 12.67%
3 Energy 11.3%
4 Healthcare 8.9%
5 Communication Services 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSGP icon
1
CoStar Group
CSGP
$11.7B
$45.4M 48.34%
1,530,070
-238,200
-13% -$6.98M
LPLA icon
2
LPL Financial
LPLA
$28.3B
$11.9M 12.67%
208,401
SBR
3
Sabine Royalty Trust
SBR
$1.06B
$10.6M 11.3%
239,317
+53,317
+29% +$2.27M
SRNE
4
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$6.61M 7.03%
1,738,232
-1,061,558
-38% -$2.76M
URGN icon
5
UroGen Pharma
URGN
$1.86B
$4.74M 5.04%
127,313
-7,687
-6% -$274K
IBRX icon
6
ImmunityBio
IBRX
$7.51B
$3.63M 3.86%
808,974
-2,582,565
-76% -$12.2M
PLAY icon
7
Dave & Buster's
PLAY
$377M
$3.31M 3.52%
60,000
PLYA
8
DELISTED
Playa Hotels & Resorts
PLYA
$3.24M 3.44%
300,000
APPF icon
9
AppFolio
APPF
$6.38B
$2.38M 2.53%
+57,372
New +$2.57M
UNG icon
10
CALL
United States Natural Gas Fund
UNG
$456M
$1.51M 1.61%
+4,059
New +$392K
NH
11
DELISTED
NantHealth, Inc
NH
$611K 0.65%
13,358
-2,564
-16% -$136K
ADVM
12
DELISTED
Adverum Biotechnologies
ADVM
-1,500
Closed -$55K
EDIT icon
13
Editas Medicine
EDIT
$396M
-41,324
Closed -$992K
EMB icon
14
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
-70,000
Closed -$8.09M
FXY icon
15
Invesco CurrencyShares Japanese Yen Trust
FXY
$438M
-31,245
Closed -$2.67M
MDXG icon
16
MiMedx Group
MDXG
$602M
-500,000
Closed -$5.94M
UNIT
17
Uniti Group
UNIT
$2.36B
-410,700
Closed -$6.02M
KITE
18
DELISTED
Kite Pharma, Inc.
KITE
-2,410,034
Closed -$433M

Similar funds

Wildcat Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Wildcat Capital Management held 18 positions worth $94M, down 83% from $558M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Wildcat Capital Management withdrew a net $474M in Q4 2017, closing 7 positions and reducing 5 holdings. Its most notable exit was Kite Pharma, Inc., an estimated $433M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 48% of assets, up from 9.6% a quarter earlier, followed by Financials and Energy.

Against the trend, Wildcat Capital Management opened a new position in AppFolio worth $2.38M.

  • Wildcat Capital Management's largest Q4 2017 buy was AppFolio: 57,372 shares worth $2.38M.
  • Wildcat Capital Management added most to Sabine Royalty Trust in Q4 2017, an estimated $2.27M increase.
  • Wildcat Capital Management's biggest Q4 2017 reduction was ImmunityBio, cutting an estimated $12.2M.
  • Wildcat Capital Management fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $433M.
  • Wildcat Capital Management's ten largest holdings make up 99% of its $94M portfolio in Q4 2017.
  • Wildcat Capital Management opened 2 new positions and closed 7 in Q4 2017.
  • Wildcat Capital Management's portfolio value fell 83% quarter-over-quarter to $94M.

Based on Wildcat Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.